2o2f
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand== | ==Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand== | ||
| - | <StructureSection load='2o2f' size='340' side='right'caption='[[2o2f | + | <StructureSection load='2o2f' size='340' side='right'caption='[[2o2f]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2o2f]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[2o2f]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2O2F OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2O2F FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=LI0:4-(4-BENZYL-4-METHOXYPIPERIDIN-1-YL)-N-[(4-{[1,1-DIMETHYL-2-(PHENYLTHIO)ETHYL]AMINO}-3-NITROPHENYL)SULFONYL]BENZAMIDE'>LI0</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=LI0:4-(4-BENZYL-4-METHOXYPIPERIDIN-1-YL)-N-[(4-{[1,1-DIMETHYL-2-(PHENYLTHIO)ETHYL]AMINO}-3-NITROPHENYL)SULFONYL]BENZAMIDE'>LI0</scene></td></tr> | |
| - | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2o2f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2o2f OCA], [https://pdbe.org/2o2f PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2o2f RCSB], [https://www.ebi.ac.uk/pdbsum/2o2f PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2o2f ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2o2f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2o2f OCA], [https://pdbe.org/2o2f PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2o2f RCSB], [https://www.ebi.ac.uk/pdbsum/2o2f PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2o2f ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | + | [https://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN] Note=A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions. | |
== Function == | == Function == | ||
| - | + | [https://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN] Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1).<ref>PMID:18570871</ref> | |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
| Line 39: | Line 38: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Belli | + | [[Category: Belli BA]] |
| - | [[Category: Bruncko | + | [[Category: Bruncko M]] |
| - | [[Category: Ding | + | [[Category: Ding H]] |
| - | [[Category: Elmore | + | [[Category: Elmore SW]] |
| - | [[Category: Fesik | + | [[Category: Fesik SW]] |
| - | [[Category: Joseph | + | [[Category: Joseph MK]] |
| - | [[Category: Kunzer | + | [[Category: Kunzer A]] |
| - | [[Category: Martineau | + | [[Category: Martineau D]] |
| - | [[Category: McClellan | + | [[Category: McClellan WJ]] |
| - | [[Category: Mitten | + | [[Category: Mitten M]] |
| - | [[Category: Ng | + | [[Category: Ng SC]] |
| - | [[Category: Nimmer | + | [[Category: Nimmer PM]] |
| - | [[Category: Oltersdorf | + | [[Category: Oltersdorf T]] |
| - | [[Category: Oost | + | [[Category: Oost TK]] |
| - | [[Category: Park | + | [[Category: Park CM]] |
| - | [[Category: Petros | + | [[Category: Petros AM]] |
| - | [[Category: Rosenberg | + | [[Category: Rosenberg SH]] |
| - | [[Category: Shoemaker | + | [[Category: Shoemaker AR]] |
| - | [[Category: Song | + | [[Category: Song X]] |
| - | [[Category: Wang | + | [[Category: Wang X]] |
| - | [[Category: Wendt | + | [[Category: Wendt MD]] |
| - | [[Category: Zhang | + | [[Category: Zhang H]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand
| |||||||||||
Categories: Homo sapiens | Large Structures | Belli BA | Bruncko M | Ding H | Elmore SW | Fesik SW | Joseph MK | Kunzer A | Martineau D | McClellan WJ | Mitten M | Ng SC | Nimmer PM | Oltersdorf T | Oost TK | Park CM | Petros AM | Rosenberg SH | Shoemaker AR | Song X | Wang X | Wendt MD | Zhang H
